Virtual QMS & Medical Device Quality FAQ

A Virtual Quality Management System (VQMS) is a fully cloud-based Quality Management System for medical device companies. Every quality record — procedures, training, supplier qualifications, design history, CAPA — lives in compliant cloud storage and is signed with 21 CFR Part 11-compliant electronic signatures. A VQMS satisfies FDA 21 CFR 820 and ISO 13485 without the cost of a physical office or paper-based document control.

If you manufacture, distribute, or design a medical device sold in the United States, the FDA requires you to operate a compliant Quality Management System under 21 CFR 820. ISO 13485 plays the same role for most international markets. Without a QMS, you cannot legally market your device, pass an FDA inspection, obtain a CE mark, or in most cases close a serious investor or strategic partner.

FDA 21 CFR 820 is the United States Quality System Regulation enforced by the FDA. ISO 13485 is the international standard for medical device quality management used by most regulators outside the US. The two are highly similar but historically not identical. The FDA's Quality Management System Regulation (QMSR), in effect since February 2, 2026, harmonizes 21 CFR 820 with ISO 13485, so a single well-designed Virtual QMS can satisfy both.

Start before you build the first design history file. The FDA's Design Controls (21 CFR 820.30) and ISO 13485 Section 7.3 apply from the moment you begin formal design and development. Companies that wait until pre-submission or first manufacturing run almost always have to redo work. A Virtual QMS implemented early scales with you and prevents costly rework.

Most BushmanQC Virtual QMS implementations take between 8 and 16 weeks from kickoff to a fully usable system, depending on the size of the company, the device classification, and how much existing documentation is already in place. The seven-step implementation process is structured so each phase delivers a usable, audit-ready piece of the system rather than waiting until the end.

CAPA stands for Corrective and Preventive Action. It is the process by which a medical device company identifies a quality problem, investigates the root cause, takes corrective action, and prevents recurrence. CAPA is one of the most-cited subsystems in FDA inspections — a weak CAPA program is the single most common reason for Form 483 observations and Warning Letters. BushmanQC builds CAPA programs that are simple to operate and defensible during an inspection.

A Virtual QMS removes three of the largest compliance cost drivers: physical office space and document storage, dedicated headcount to manage paper-based document control, and the rework that comes from non-compliant systems. Cloud-based storage, electronic signatures, and a remote-first operating model let small medical device companies achieve full FDA and ISO compliance at a fraction of the cost of a traditional in-house quality function.

Yes — when implemented correctly. 21 CFR Part 11 governs how the FDA accepts electronic records and electronic signatures in place of paper. Every BushmanQC Virtual QMS uses Part 11-validated cloud storage, audit trails, user qualification, and electronic signature workflows so that every quality record is admissible during an FDA inspection.

Under the harmonized QMSR and ISO 13485, a documented Quality Manual is required regardless of device class. The level of detail can scale with the complexity of the product, but every medical device company — Class I, II, or III — needs a Quality Manual that defines the scope of the QMS, identifies the processes, and shows how they interact.

Supplier management — also called purchasing controls (21 CFR 820.50) or control of externally provided processes (ISO 13485 7.4) — is the process by which a medical device company qualifies, monitors, and re-qualifies the suppliers that provide components, services, or contract manufacturing. A defensible supplier management program includes a risk-based qualification process, an approved supplier list, and ongoing performance monitoring.

The best preparation is a QMS that operates the same way every day, not one that gets cleaned up the week before an inspection. BushmanQC's approach focuses on building documentation, training, and CAPA habits that are continuously audit-ready. Closer to an inspection, we run a mock audit, prepare a back-room support process, and coach the management team on inspection etiquette.

Yes. The FDA's Quality Management System Regulation (QMSR) took effect on February 2, 2026, replacing the old 21 CFR 820 QSR provisions with requirements harmonized to ISO 13485. Companies that have not yet updated their QMS, terminology, and procedures are now operating out of compliance and should remediate promptly. New companies should be implemented to the QMSR from day one. BushmanQC supports both new implementations and remediation of existing quality systems for the QMSR transition.

The free 30-minute consultation is a no-obligation conversation with Nellie Bushman to understand your medical device, your current state of QMS readiness, and the most common gaps for a company at your stage. You will leave with a clear answer about which Quality Management System fits your situation and what the next concrete step is — whether or not you choose to engage BushmanQC.

Most BushmanQC clients are small or startup medical device companies between pre-seed and Series B. Many are first-time medical device founders, founders coming from drug or diagnostics backgrounds, or established hardware companies entering the regulated medical space. The common thread is a small team that wants to be compliant from day one without standing up a full in-house quality department.

The fastest way to get started is to book a free 30-minute consultation with Nellie Bushman. In that call we will scope your situation, identify the right level of Virtual QMS for your stage, and outline a concrete next step. You can also email nellie@bushmanqc.com directly.